JPRN-UMIN000008207尚未招募未知
Prevention of Cholesterol Embolization during Endovascular and Open aneurysm repair with Pitavastatin [PROCEDURE] Study - PROCEDURE study
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1) patients who have already prescribed statin (2) Renal function: CKD 4 and 5 (3) pregnancy (4) severe liver dysfunction (5) patients who have had drugs of contraindication (6) patients of whom the clinical investigator judged as inappropriate for this study
研究者
相似试验
进行中（未招募）
1 期
Cholesterol lowering with the drug evolocumab to prevent coronary artery disease in new heart transplantsCardiac allograft vasculopathy in de-novo heart transplant recipientsEUCTR2017-005097-19-FIOslo University Hospital130
进行中（未招募）
1 期
Cholesterol lowering with the drug evolocumab to prevent coronary artery disease in new heart transplantsEUCTR2017-005097-19-DKOslo University Hospital130
进行中（未招募）
1 期
Cholesterol lowering in heart transplant recipientsDe novo heart transplantationMedDRA version: 20.0 Level: LLT Classification code 10066521 Term: Coronary artery disease progression System Organ Class: 100000004849EUCTR2017-005097-19-SEOslo University Hospital130
进行中（未招募）
1 期
Cholesterol lowering with the drug evolocumab to prevent coronary artery disease in new heart transplantsEUCTR2017-005097-19-NOOslo University Hospital130
已完成
不适用
Prevention of Type II Endoleak With Embolization of IMA Before Endovascular Aneurysm Repairabdominal aortic aneurysmJPRN-UMIN000022147Department of Surgery and Clinical Science, Yamaguchi University Graduate School of Medicine106